248 related articles for article (PubMed ID: 24962027)
21. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
24. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
25. Tumorigenic potential of miR-18A* in glioma initiating cells requires NOTCH-1 signaling.
Turchi L; Debruyne DN; Almairac F; Virolle V; Fareh M; Neirijnck Y; Burel-Vandenbos F; Paquis P; Junier MP; Van Obberghen-Schilling E; Chneiweiss H; Virolle T
Stem Cells; 2013 Jul; 31(7):1252-65. PubMed ID: 23533157
[TBL] [Abstract][Full Text] [Related]
26. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy.
Zhuang W; Long L; Zheng B; Ji W; Yang N; Zhang Q; Liang Z
Cancer Sci; 2012 Apr; 103(4):684-90. PubMed ID: 22192169
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of glioma initiating cells to a monoclonal anti-EGFR antibody therapy under hypoxia.
Randriarimanana T; Chateau A; Faivre B; Pinel S; Boura C
Life Sci; 2015 Sep; 137():74-80. PubMed ID: 26239438
[TBL] [Abstract][Full Text] [Related]
28. Vasorin promotes endothelial differentiation of glioma stem cells via stimulating the transcription of VEGFR2.
Qin Z; Zhong Y; Li P; Ma Z; Kang H; Huang Y; Zhong Y; Wang L
FASEB J; 2024 May; 38(10):e23682. PubMed ID: 38780524
[TBL] [Abstract][Full Text] [Related]
29. The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network.
Gürsel DB; Berry N; Boockvar JA
Neurosurgery; 2012 Feb; 70(2):N19-21. PubMed ID: 22251985
[No Abstract] [Full Text] [Related]
30. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
31. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
32. Selective calcium sensitivity in immature glioma cancer stem cells.
Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
[TBL] [Abstract][Full Text] [Related]
33. [Plasticity of malignant tumor cells].
Kofman AV
Tsitologiia; 2011; 53(10):832-3. PubMed ID: 22232941
[No Abstract] [Full Text] [Related]
34. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
35. Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling.
Hu B; Nandhu MS; Sim H; Agudelo-Garcia PA; Saldivar JC; Dolan CE; Mora ME; Nuovo GJ; Cole SE; Viapiano MS
Cancer Res; 2012 Aug; 72(15):3873-85. PubMed ID: 22665268
[TBL] [Abstract][Full Text] [Related]
36. Phage display discovery of novel molecular targets in glioblastoma-initiating cells.
Liu JK; Lubelski D; Schonberg DL; Wu Q; Hale JS; Flavahan WA; Mulkearns-Hubert EE; Man J; Hjelmeland AB; Yu J; Lathia JD; Rich JN
Cell Death Differ; 2014 Aug; 21(8):1325-39. PubMed ID: 24832468
[TBL] [Abstract][Full Text] [Related]
37. Spatial Heterogeneity of Invading Glioblastoma Cells Regulated by Paracrine Factors.
Chonan Y; Yamashita T; Sampetrean O; Saya H; Sudo R
Tissue Eng Part A; 2022 Jul; 28(13-14):573-585. PubMed ID: 34841881
[TBL] [Abstract][Full Text] [Related]
38. ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells.
Chen X; Chen L; Zhang R; Yi Y; Ma Y; Yan K; Jiang X; Wang X
Neurosci Lett; 2013 Mar; 537():44-9. PubMed ID: 23356982
[TBL] [Abstract][Full Text] [Related]
39. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
[TBL] [Abstract][Full Text] [Related]
40. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
